Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Severe Dumping and Persistent Obesity in a Post-Roux-en-Y Gastric Bypass Patient With a Non-discernible Gastric Pouch and Symptomatic Improvement on Tirzepatide: A Case Report
Cureus, 2026;18(7):e113316
Beyond Fat: Reframing MASLD Through Genetics, Clonal Biology, and Precision Hepatology
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis
Endocrinology, diabetes & metabolism;9(4):e70291
Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: A Target Trial Emulation
JACC. Advances;5(7):102917
Advances in proteomics research related to semaglutide: evidence from humans and animals
Journal of endocrinological investigation, 2026
Impact of semaglutide on cognitive function in patients with type 2 diabetes and mild cognitive impairment: a 24-month observational study
Internal and emergency medicine, 2026
Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?
European journal of internal medicine, 2026;:107099
Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial
BMJ open, 2026;16(7):e118191
One receptor, two opposite approaches: efficacy and tolerability of GIPR agonism and antagonism in obesity pharmacotherapy
Appetite, 2026;:108723
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study
Joint diseases and related surgery, 2026;37(3):822-837
The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents
Frontiers in gastroenterology (Lausanne, Switzerland), 2026;5:1850915
Can semaglutide influence tumor biomarkers? Insight from a clinical case
Journal of food and drug analysis;34(2):172-175
When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning
Fundamental & clinical pharmacology;40(4):e70109
Multi-target-directed drugs: new additions in 2025 and post-marketing safety surveillance of drugs marketed in 2022-2024
Pharmacological reports : PR, 2026
Cost-Effectiveness of Endoscopic Bariatric Therapies Compared with Laparoscopic Sleeve Gastrectomy and Semaglutide
Obesity surgery, 2026
Implications of Generic Semaglutide Availability on the Cost-Effectiveness of GLP-1RA for Guideline-Indicated Patients With Type 2 Diabetes
The Canadian journal of cardiology, 2026
Cardiovascular Outcomes of GLP-1-Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials
Obesity reviews : an official journal of the International Association for the Study of Obesity, 2026;:e70198
Hypersensitivity Reaction to Tirzepatide With Demonstrated Tolerance to Semaglutide: A Case Report
Clinical case reports, 2026;14(7):e73183
AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models
Nature communications, 2026;17(1)
Therapeutic Potential of Incretin-Based Therapies for Alcohol Use Disorder – A narrative review of available clinical evidence
Biological psychiatry, 2026